All posts by: Michael Zand

About Michael Zand

Stem cell transplant for severe scleroderma improves survival, quality of life – National Institutes of Health (press release)

Continue reading

2018-01-03 NEWS

National Institutes of Health (press release)

Stem cell transplant for severe scleroderma improves survival, quality of life
National Institutes of Health (press release)
New clinical trial findings show that a therapeutic regimen involving transplantation of a person’s own blood-forming stem cells can improve survival and quality of life for people with severe scleroderma, a life-threatening autoimmune disease. The
Stem Cell Transplant Succeeds in SclerodermaMedPage Today
Study shows stem cell transplant is better than drug therapy for sclerodermaEurekAlert (press release)
Stem Cell Transplant Shows Promise for Immune Disorder SclerodermaHealthDay
MilTech –Island Post Gazette
all 8 news articles »
Continue reading

2018-01-03 NEWS

Price tag on gene therapy for rare form of blindness: $850K
WPXI Pittsburgh
Approved last month, Luxturna, is the nation’s first gene therapy for an inherited disease. It requires a 45-minute operation in which a tiny needle delivers a replacement gene to the retina, tissue at the back of the eye that converts light into

and more »